Lisata Therapeutics Inc (LSTA)

[F1ash]

BASKING RIDGE, N.J. (December 1, 2017) – Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiology indications, announces today that David J. Mazzo, PhD, President and Chief Executive Officer of the Company, will present at the 10th Annual LD Micro Main Event on Thursday, December 7, 2017 at 10:30 a.m. PST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Dr. Mazzo’s presentation will be webcast live on the internet and can be accessed by visiting the Investor Relations section of the Company’s website at www.caladrius.com. Following the presentation, a replay of the webcast will be archived on Caladrius’ website for 90 days.